Modern cancer treatment often includes participation in clinical trials or the use of emerging therapies. These treatments may involve experimental drugs, new immunotherapies, or advanced surgical procedures. While these treatments are designed to improve survival, they sometimes involve medical risks.
In some life insurance and accidental death claims, insurers attempt to deny benefits when the insured dies during or after participation in an experimental cancer treatment. The denial may rely on policy exclusions such as suicide, voluntary risk taking, or experimental medical treatment.
Attorney Christian Lassen represents beneficiaries nationwide in disputes involving denied life insurance claims.
What Counts as an Experimental Treatment
Clinical trials are research studies designed to evaluate new medical therapies. These trials are often conducted at major hospitals or cancer centers and are carefully regulated.
Experimental cancer treatments may include:
New chemotherapy or immunotherapy drugs
Targeted therapies under investigation
Gene based treatments
Experimental radiation protocols
Investigational surgical techniques
Patients often enroll in these trials when standard treatments have been exhausted or when new therapies show promising results.
Why Insurers Scrutinize Clinical Trial Deaths
When a death occurs during or after a clinical trial, insurers may closely review the circumstances surrounding the treatment.
Insurers sometimes argue that the insured voluntarily accepted a higher medical risk by participating in an experimental study. In certain cases, insurers attempt to characterize the death as resulting from a voluntary medical procedure rather than a covered event.
Some denial letters may cite:
Voluntary exposure to medical risk
Participation in experimental treatment
Self inflicted injury exclusions
Suicide provisions in accidental death policies
These arguments attempt to reframe the circumstances surrounding the death.
The "Voluntary Risk" Argument
A common insurer argument is that the insured knowingly accepted the risks of an experimental treatment.
For example:
A patient enrolls in a clinical trial for a new cancer therapy
The treatment produces severe complications
The patient dies from those complications
The insurer may argue that the death resulted from a voluntary decision to undergo experimental treatment rather than from a covered cause under the policy.
Suicide Allegations in Rare Cases
In rare cases involving accidental death policies, insurers have attempted to characterize participation in a risky medical treatment as a form of self inflicted injury.
The argument typically suggests that the insured knowingly engaged in a medical procedure that carried serious risk.
These cases can become controversial because clinical trials are supervised medical treatments designed to help patients rather than harm them.
Why These Denials Can Be Controversial
Clinical trials are an essential part of modern medical progress. Patients often enroll in these programs with the guidance of oncologists and specialized treatment centers.
Participation in a clinical trial typically involves:
Institutional review board approval
Detailed informed consent procedures
Medical supervision by qualified physicians
Careful monitoring for complications
Because of this structure, many families find it surprising when insurers attempt to frame the treatment as voluntary risk taking.
Medical Records and Trial Documentation
When a claim involves an experimental cancer treatment, several types of records may become important.
These may include:
Clinical trial consent forms
Hospital and oncology records
Treatment protocols
Physician statements about the treatment
Medical examiner reports describing the cause of death
These materials can help explain the circumstances of the treatment and the events leading to the death.
The Role of Policy Language
The outcome of these claims often depends on the specific language in the insurance policy.
Policies sometimes contain provisions related to:
Medical treatment exclusions
Self inflicted injury exclusions
Hazardous activities
Suicide clauses in accidental death policies
Insurers may rely on these provisions when attempting to deny claims involving experimental treatments.
Legal Help With Experimental Treatment Claim Denials
Life insurance disputes involving experimental cancer treatments can raise complex questions about how policy language applies to modern medical care. Insurers sometimes attempt to characterize participation in clinical trials as voluntary risk taking or self inflicted injury.
The Lassen Law Firm focuses exclusively on life insurance disputes nationwide. Attorney Christian Lassen has more than 25 years of experience representing beneficiaries in denied life insurance claims.
If a life insurance claim has been denied after the insured died during an experimental cancer treatment or clinical trial, legal review may help determine whether the insurer properly applied the policy provisions.